Lcn2 protects from cisplatin induced AKI by regulating DNA damage response via EGFR activation
Aniela Zablocki, Eloïse Marques, Lucie Yammine, Clément Nguyen, Fabiola Terzi, Morgan Gallazzini
This study shows Lcn2 protects kidneys from cisplatin-induced AKI by activating the EGFR pathway to reduce apoptosis.
bioRxiv · May 3, 2024 · PreprintCell Biology